CD44+CD324− expression and prognosis in gastric cancer patients
Authors:
- 9 June 2014
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 110 (6) , 727-733
Abstract
Purpose: To evaluate the frequency of cancer stem cell marker CD44 combined CD324 expression in gastric cancer specimens and association of the expression with survival of gastric cancer patients.Methods: A total of 203 patients with primary gastric cancer who underwent curative gastric resection with lymphadenectomy were studied. The expression of CD44 and CD324 was analyzed by immunohistochemistry and the association of CD44 and CD324 expression analyzed by clinicopathological characteristics. Survival of the patients was evaluated.Results: CD44+CD324− tumors showed strong correlation with positive lymph node metastasis. Patients with CD44−CD324+ had a significantly better prognosis (54.8%) than that with CD44+CD324− (24.5%). A multivariate Cox proportional hazards model using those variables associated with survival in our study (depth of invasion, tumor size, lymph node metastasis, gastrectomy, CD44 expression, CD324 expression, CD44 and CD324 expression) revealed that CD44+CD324− expression (P = 0.005) was one of significant independent prognostic indicator, whereas CD44 expression (P = 0.081), CD324 expression (P = 0.068) was not.Conclusion: CD44+CD324− expression was one of significant independent prognostic survival factors for patients with gastric cancer. J. Surg. Oncol. 2014 110:727–733.Keywords
Funding Information
- National Natural Science Foundation of China (81101633)
- Natural Science Foundation of Liaoning Province (201202047)
- Science and Technology Project of Dalian (2012E15SF142)
This publication has 24 references indexed in Scilit:
- The recently suggested intestinal cancer stem cell markerDCLK1is an epigenetic biomarker for colorectal cancerEpigenetics, 2014
- In Vitro Selection of Modified RNA Aptamers Against CD44 Cancer Stem Cell MarkerNucleic Acid Therapeutics, 2013
- CD133+, CD166+CD44+, and CD24+CD44+ Phenotypes Fail to Reliably Identify Cell Populations with Cancer Stem Cell Functional Features in Established Human Colorectal Cancer Cell LinesStem Cells Translational Medicine, 2012
- Identification of Glycoprotein Markers for Pancreatic Cancer CD24+CD44+ Stem-like Cells Using Nano-LC–MS/MS and Tissue MicroarrayJournal of Proteome Research, 2012
- Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancerPathology International, 2011
- Omental milky spots in screening gastric cancer stem cellsNeoplasma, 2011
- Gastric carcinogenesis and the cancer stem cell hypothesisGastric Cancer, 2010
- Omental milky spots – highly efficient “natural filter” for screening gastric cancer stem cellsMedical Hypotheses, 2009
- Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44Stem Cells, 2009
- Cancer Stem Cells: A Step Toward the CureJournal of Clinical Oncology, 2008